SEC Form 4 · accession 0001638727-15-000001
Lexaria Bioscience Corp. · LXRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Martin Docherty
Officer — President
Period of report
Mar 26, 2015
Accepted (ET)
Apr 7, 2015 · 3:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348362
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $0.10 | Mar 26, 2015 | P | 500,000 | A | Mar 26, 2015 | Mar 26, 2020 | Common Shares | 500,000 | 500,000 | D |